Obesity pharmacotherapies and cognition | Science

Pharmacotherapies for obesity and type 2 diabetes are increasingly being evaluated for their effects on cognition and brain health. Evidence from preclinical models, observational cohorts, and clinical trials has intensified interest, but findings remain ...

Source: https://www.science.org/doi/10.1126/science.aek9987